Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
30 September
Arch Therapeutics, Inc. has filed 558 SEC EDGAR filings since 05 Jan 2012

SEC filing history

Showing 176-200 of 558 matching filings.

Per page
25
Current page
8
424B3 File 333-253588

424B3

Filing date
10 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-253588

EFFECT filing

Filing date
09 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-390512

D filing

Filing date
25 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-194745

424B3

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-194745

424B3

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54986

FORM 8-K

Filing date
12 Feb 2021
Reporting date
11 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-234811

EFFECT filing

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87522

SCHEDULE 13G/A

Filing date
22 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-252133

FORM S-8

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54986

FORM 8-K

Filing date
04 Jan 2021
Reporting date
04 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54986

FORM 8-K

Filing date
31 Dec 2020
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
10 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
10 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54986

FORM 8-K

Filing date
10 Nov 2020
Reporting date
06 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-234811

424B3

Filing date
11 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .